glp-1 and insulin GLP-1R Diabetes Clinical Focus on GLP-1 Agonists
Description
FDA approves Jardiance (empagliflozin) tablets to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease
This unique dual-action approach helps with managing appetite suppression, digestion time, and insulin levels
- Potassium (Venous only This parameter is not reported in capillary/home kits samples)
Fits: 3mL vials up to 17mm in diameter
Designed in an easy-to-use tablet format, this product provides a convenient alternative to injectable GLP-1 options
